Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$1.21−$0.0150 (−1.23%) on the dayAs of the close; data may be delayed.
ALDX price, last 12 months
Key stats
- Previous close
- $1.22
- Open
- $1.23
- Day range
- $1.20 – $1.28
- 52-week range
- $1.07 – $5.93
- Volume
- 644.9K
- Avg volume (20 days)
- 652.1K
- Market cap
- $72.7M
Performance
1W−11.4%
1M−22.8%
3M−34.2%
6M−34.5%
YTD−76.7%
1Y−76.0%
vs S&P 500, 1Y−92.7 pts
Technicals and fundamentals
About Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $72.7M